B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
about
Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesOrally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinibT cell coinhibition and immunotherapy in human breast cancerB7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcomeProteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway.B7-H3 silencing by RNAi inhibits tumor progression and enhances chemosensitivity in U937 cells.Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitorsImmunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1αSoluble B7-H3 promotes the invasion and metastasis of pancreatic carcinoma cells through the TLR4/NF-κB pathway.B7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.The co-stimulatory molecule B7-H3 promotes the epithelial-mesenchymal transition in colorectal cancer.Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis.The B7 homologues and their receptors in hematologic malignancies.JAK2 inhibition for the treatment of hematologic and solid malignancies.B7-H3-mediated tumor immunology: Friend or foe?Selective blockade of B7-H3 enhances antitumour immune activity by reducing immature myeloid cells in head and neck squamous cell carcinoma.Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.Effective down-regulation of signal transducer and activator of transcription 3 (STAT3) by polyplexes of siRNA and lipid-substituted polyethyleneimine for sensitization of breast tumor cells to conventional chemotherapy.The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes.MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer.Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.B7-H3 promotes gastric cancer cell migration and invasion.Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells.Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling.B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
P2860
Q26825652-C8AA074C-59F2-4DF5-B74E-4C449EC527AAQ33654186-62884751-DDA5-4C41-8AB8-B184EEFDB2F8Q33936154-6CFB4044-E1D0-4BE4-859D-19B04C0E7A2AQ34105913-5913B092-B2A4-40E6-B1F5-C10BB66003F2Q35057121-3CB867F9-2D48-4FC7-8C43-2925883F7E37Q35104159-8B7E1FE1-ED15-43FF-9A3F-A71E362E44DCQ35530644-FE970F1C-F8B3-4217-B1C8-B3557D39E915Q35867721-013B733A-9EEA-4DAF-BFF1-71192ED26056Q36916365-15439DAB-20B1-4E78-9797-89308A2A80B2Q36921665-B0299817-7758-4E9C-8C69-1729BCD9EEC3Q36980286-94FB038C-DF93-4DA0-B020-E02BF7FBDA75Q37140050-DBBE7B5B-6098-4DCA-9FFB-E8EF85B35E6EQ37362510-3226373B-607B-4E51-AB42-2948EC8AF529Q37563260-EA3B2C47-7AD3-4B4F-88FA-F3253D06DA8FQ37988965-6A09D0B0-3C0B-4077-A274-1C4F9B8B515FQ38001733-095DCFF9-C23C-4C38-B6F0-2D62D0B19B82Q38135281-DBDF7BA1-D76E-4DD3-9119-14C23E30C2D6Q38731474-0D1FC709-4E24-4F0E-AE8B-2A7E11E46566Q38909198-C647FD35-347E-4CDA-A1E9-C491352A67E7Q39069248-14EAB059-AAAE-4B00-892E-9C0FE32C6807Q39160982-19A2A8FA-FA28-4737-96D1-F3FDA5A9A393Q39524901-366BF6A7-CF69-44FE-9AA6-48D62E5233D2Q39987020-A594A827-0A56-4262-A2E2-76F70F1794A0Q41809391-7409B2CD-9B20-483E-AA59-036C66E7E834Q42700893-7833B360-43E9-430C-B310-876D5249351DQ48131888-71502147-659F-4667-9B22-83ABBB0617E1Q49300596-4559B276-84C6-4505-B34F-7056738593D2Q57176931-7594F2ED-4704-45A0-B250-7099B5DF28D8
P2860
B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@ast
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@en
type
label
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@ast
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@en
prefLabel
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@ast
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@en
P2093
P2860
P1476
B7-H3 silencing increases pacl ...... ng Jak2/Stat3 phosphorylation.
@en
P2093
Alexandr Kristian
Christina Tekle
Jahn Marthin Nesland
Oystein Fodstad
Yih-Wen Chen
P2860
P304
P356
10.1158/1535-7163.MCT-11-0072
P577
2011-04-25T00:00:00Z